 Home > Active Ingredient News > Antitumor Therapy > Tecentriq first-line treatment of metastatic non-small cell lung cancer, CHMP holds positive opinions

Tecentriq first-line treatment of metastatic non-small cell lung cancer, CHMP holds positive opinions

 Last Update: 2021-04-13
 Source: Internet
 Author: User

Tags

water based pens

3 8 1 4

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Roche announced today that the European Medicines Management Agency (EMA) Committee for Medicinal human use (CHMP) has recommended approval of the Tecentriq® (atezolizumab) as a high expression of PD-L1 and no epidermal growth factor receptor (EGFR) or anaplastic lymphoma First-line therapy for metastatic non-small cell lung cancer ( NSCLC ) with abnormal genomic tumors of ALK .

Managing lymphoma NSCLC

The CHMP recommendations are based on data from the Phase III IMpower110 study, which showed that Tecentriq monotherapy can increase overall survival (OS) by 7.

The study showed that compared with chemotherapy, Tecentriq monotherapy can increase overall survival (OS) by 7.

If approved, Tecentriq will provide a new treatment option without the adverse reactions associated with chemotherapy.

It will also be the first and only single-dose cancer immunotherapy with three modes of administration , allowing for once every two, three or four weeks to give doctors and patients the flexibility to manage treatment.

Original source:

href="" target="_blank" rel="noopener">leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.